Moreover, in AML patients, reconstructed existing mutations, such as expansion of FLT3-ITD, promote the expression of the antiapoptotic protein MCL-1 and reduce the expression of proapoptotic proteins to interfere with intrinsic apoptosis pathways through the PI3K/AKT signalling pathway. Here, FLT3 is linked to acute myeloid leukemia.